Revolution Medicines RVMDW
NASDAQ RVMDW
$9.89 +1.24 (+14.34%)
At close: Nov 6, 2026 · 4:00 PM EST

Revolution Medicines (RVMDW) Income After Tax (2019 - 2026)

Updated

Revolution Medicines (RVMDW) posted Income After Tax of -$644.37 million for Q2 2026, compared with -$247.79 million a year earlier.

Analysis

Revolution Medicines (RVMDW) Income After Tax (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Income After Tax at Revolution Medicines was -$1.77 billion; for FY2025, it was -$1.13 billion.

  • In prior years, Revolution Medicines' Income After Tax was -$600.05 million in FY2024, -$436.37 million in FY2023, -$248.71 million in FY2022 and -$187.09 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Income After Tax in data going back to Q1 2019.
  • According to Business Quant data, Income After Tax for the three prior quarters was -$453.82 million (Q1 2026), -$364.89 million (Q4 2025) and -$305.21 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -407.46 Mn
Jun 30, 2026 -644.37 Mn
Mar 31, 2026 -453.82 Mn
Dec 31, 2025 -364.89 Mn
Sep 30, 2025 -305.21 Mn
Jun 30, 2025 -247.79 Mn
Mar 31, 2025 -213.42 Mn
Dec 31, 2024 -194.52 Mn
Sep 30, 2024 -156.29 Mn
Jun 30, 2024 -133.23 Mn
Mar 31, 2024 -116.00 Mn
Dec 31, 2023 -161.54 Mn
Sep 30, 2023 -108.43 Mn
Jun 30, 2023 -98.30 Mn
Mar 31, 2023 -68.10 Mn
Dec 31, 2022 -56.51 Mn
Sep 30, 2022 -73.33 Mn
Jun 30, 2022 -61.22 Mn
Mar 31, 2022 -57.65 Mn
Dec 31, 2021 -52.68 Mn
API Access

Revolution Medicines Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RVMDW&period=max&api_key=YOUR_API_KEY